First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?
First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen? For the quality assessment, six studies fulfilled 85% of the CHEERS checklist requirements and are deemed good quality. Neoadjuvant therapy refers to any treatment including chemotherapy, endocrine therapy, or radiation that is given prior to surgery. This can be a mean to down-stage the tumor …
First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen? Leer más »